Xueying Ren

Hangzhou, 310005, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Lonidamine ameliorates MASH by reducing SREBP1 and inhibiting the MAPK pathway.

Lonidamine ameliorates MASH by reducing SREBP1 and inhibiting the MAPK pathway.

Journal: Acta biochimica et biophysica Sinica

Published: March 06, 2026

Ferredoxins: master regulators in mitochondrial redox homeostasis and programmed cell death.

Ferredoxins: master regulators in mitochondrial redox homeostasis and programmed cell death.

Journal: Redox biology

Published: August 14, 2025

Protein lipoylation in cancer: metabolic reprogramming and therapeutic potential.

Protein lipoylation in cancer: metabolic reprogramming and therapeutic potential.

Journal: Cell death discovery

Published: March 01, 2025

GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes.

GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes.

Journal: Free radical biology & medicine

Published: April 23, 2024

Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis.

Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis.

Journal: Redox biology

Published: November 24, 2023

Correction: Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62-Keap1-NRF2 pathway.

Correction: Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62-Keap1-NRF2 pathway.

Journal: Cellular & molecular biology letters

Published: August 24, 2023

Corrigendum to "Identification of Frataxin as a regulator of ferroptosis" [Redox Biol. 32 (2020) 101483].

Corrigendum to "Identification of Frataxin as a regulator of ferroptosis" [Redox Biol. 32 (2020) 101483].

Journal: Redox biology

Published: July 30, 2023

JQ1 attenuates contrast-induced acute kidney injury through the upregulation of autophagy and inhibition of inflammation.

JQ1 attenuates contrast-induced acute kidney injury through the upregulation of autophagy and inhibition of inflammation.

Journal: International urology and nephrology

Published: February 15, 2023

Copper exerts cytotoxicity through inhibition of iron-sulfur cluster biogenesis on ISCA1/ISCA2/ISCU assembly proteins.

Copper exerts cytotoxicity through inhibition of iron-sulfur cluster biogenesis on ISCA1/ISCA2/ISCU assembly proteins.

Journal: Free radical biology & medicine

Published: December 28, 2022

Evaluation of Pharmacokinetics and Safety With Bioequivalence of Voriconazole Injection of 2 Formulations in Chinese Healthy Volunteers: Bioequivalence Study.

Evaluation of Pharmacokinetics and Safety With Bioequivalence of Voriconazole Injection of 2 Formulations in Chinese Healthy Volunteers: Bioequivalence Study.

Journal: Clinical pharmacology in drug development

Published: October 14, 2022

Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62-Keap1-NRF2 pathway.

Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62-Keap1-NRF2 pathway.

Journal: Cellular & molecular biology letters

Published: June 11, 2022

A novel RNA modification prognostic signature for predicting the characteristics of the tumor microenvironment in gastric cancer.

A novel RNA modification prognostic signature for predicting the characteristics of the tumor microenvironment in gastric cancer.

Journal: Frontiers in oncology

Published: March 26, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026